2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
October 11th 2021
Bradley McGregor, MD, discusses ongoing trials in patients with non-clear cell renal cell carcinoma (RCC).
January 7th 2021
Bradley McGregor, MD, discusses the focus of future research efforts in renal cell carcinoma.
September 15th 2020
Bradley McGregor, MD, discusses future research in metastatic castration-resistant prostate cancer.
August 25th 2020
Bradley McGregor, MD, discusses the evolving treatment landscape of renal cell carcinoma.
December 5th 2018
In contrast to the wide array of available therapies in the metastatic setting of renal cell carcinoma, in patients with localized disease, the results of trials investigating adjuvant systemic therapy after nephrectomy have so far been underwhelming.